Kyle L. Flannigan

2.1k total citations
38 papers, 1.6k citations indexed

About

Kyle L. Flannigan is a scholar working on Immunology, Molecular Biology and Biochemistry. According to data from OpenAlex, Kyle L. Flannigan has authored 38 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 12 papers in Molecular Biology and 11 papers in Biochemistry. Recurrent topics in Kyle L. Flannigan's work include Sulfur Compounds in Biology (11 papers), Gut microbiota and health (10 papers) and IL-33, ST2, and ILC Pathways (6 papers). Kyle L. Flannigan is often cited by papers focused on Sulfur Compounds in Biology (11 papers), Gut microbiota and health (10 papers) and IL-33, ST2, and ILC Pathways (6 papers). Kyle L. Flannigan collaborates with scholars based in Canada, United States and Portugal. Kyle L. Flannigan's co-authors include John L. Wallace, Timothy L. Denning, Simon A. Hirota, Rory W. Blackler, Akihito Harusato, Duke Geem, José G. Ferraz, André G. Buret, Rui Wang and Jean‐Paul Motta and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Kyle L. Flannigan

37 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kyle L. Flannigan Canada 22 666 462 383 243 196 38 1.6k
Linda Vong Canada 15 524 0.8× 257 0.6× 413 1.1× 184 0.8× 94 0.5× 37 1.4k
David T. Bolick United States 29 807 1.2× 125 0.3× 309 0.8× 255 1.0× 447 2.3× 43 1.9k
Thad W. Vickery United States 11 407 0.6× 249 0.5× 485 1.3× 168 0.7× 289 1.5× 17 1.5k
Tobias Polte Germany 27 762 1.1× 112 0.2× 448 1.2× 425 1.7× 200 1.0× 43 2.1k
Neil E. Hubbard United States 28 824 1.2× 315 0.7× 415 1.1× 364 1.5× 63 0.3× 75 2.9k
Yucun Liu China 28 1.3k 2.0× 210 0.5× 212 0.6× 284 1.2× 123 0.6× 101 2.5k
Josette Fauvel France 24 1.0k 1.5× 175 0.4× 187 0.5× 469 1.9× 168 0.9× 38 1.9k
Rachel Marion‐Letellier France 23 631 0.9× 118 0.3× 231 0.6× 308 1.3× 67 0.3× 46 1.9k
Timothy D. Bigby United States 24 392 0.6× 103 0.2× 325 0.8× 485 2.0× 250 1.3× 53 1.6k

Countries citing papers authored by Kyle L. Flannigan

Since Specialization
Citations

This map shows the geographic impact of Kyle L. Flannigan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle L. Flannigan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle L. Flannigan more than expected).

Fields of papers citing papers by Kyle L. Flannigan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyle L. Flannigan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle L. Flannigan. The network helps show where Kyle L. Flannigan may publish in the future.

Co-authorship network of co-authors of Kyle L. Flannigan

This figure shows the co-authorship network connecting the top 25 collaborators of Kyle L. Flannigan. A scholar is included among the top collaborators of Kyle L. Flannigan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyle L. Flannigan. Kyle L. Flannigan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Flannigan, Kyle L., Elizabeth M. Hughes, Matthew Stephens, et al.. (2025). Indole-3-propionic acid protects medium-diversity colitic mice via barrier enhancement preferentially over anti-inflammatory effects. American Journal of Physiology-Gastrointestinal and Liver Physiology. 328(6). G696–G715. 2 indexed citations
2.
Flannigan, Kyle L., Laurie Alston, Hong Zhang, et al.. (2025). Mycobacterium avium subspecies paratuberculosis targets M cells in enteroid-derived monolayers through interactions with β1 integrins. American Journal of Physiology-Gastrointestinal and Liver Physiology. 328(5). G482–G501.
3.
Li, Shuhua, Arthur Wang, Lucas Kraemer, et al.. (2024). Enteric tuft cells coordinate timely expulsion of the tapeworm Hymenolepis diminuta from the murine host by coordinating local but not systemic immunity. PLoS Pathogens. 20(7). e1012381–e1012381. 1 indexed citations
4.
Flannigan, Kyle L., et al.. (2022). The Pregnane X Receptor and Indole-3-Propionic Acid Shape the Intestinal Mesenchyme to Restrain Inflammation and Fibrosis. Cellular and Molecular Gastroenterology and Hepatology. 15(3). 765–795. 60 indexed citations
5.
Flannigan, Kyle L., et al.. (2019). Vancomycin relieves mycophenolate mofetil–induced gastrointestinal toxicity by eliminating gut bacterial β-glucuronidase activity. Science Advances. 5(8). eaax2358–eaax2358. 90 indexed citations
6.
Flannigan, Kyle L., Vivek Krishna Pulakazhi Venu, Laurie Alston, et al.. (2019). Pregnane X Receptor Activation Triggers Rapid ATP Release in Primed Macrophages That Mediates NLRP3 Inflammasome Activation. Journal of Pharmacology and Experimental Therapeutics. 370(1). 44–53. 26 indexed citations
7.
Flannigan, Kyle L., et al.. (2019). A16 SENSING OF A MICROBIAL METABOLITE BY FIBROBLASTS THROUGH THE PREGNANE X RECEPTOR RESTRAINS INFLAMMATION AND FIBROSIS IN MICE. Journal of the Canadian Association of Gastroenterology. 2(Supplement_2). 30–31. 3 indexed citations
8.
Abo, Hirohito, Kyle L. Flannigan, Duke Geem, et al.. (2019). Combined IL-2 Immunocomplex and Anti-IL-5 mAb Treatment Expands Foxp3+ Treg Cells in the Absence of Eosinophilia and Ameliorates Experimental Colitis. Frontiers in Immunology. 10. 459–459. 20 indexed citations
9.
Alston, Laurie, et al.. (2019). The xenobiotic sensing pregnane X receptor regulates tissue damage and inflammation triggered by C difficile toxins. The FASEB Journal. 34(2). 2198–2212. 17 indexed citations
10.
Flannigan, Kyle L., Laurie Alston, Xuemei Wang, et al.. (2018). An intact microbiota is required for the gastrointestinal toxicity of the immunosuppressant mycophenolate mofetil. The Journal of Heart and Lung Transplantation. 37(9). 1047–1059. 67 indexed citations
11.
Paul‐Clark, Mark J., Nicholas S. Kirkby, Melissa V. Chan, et al.. (2016). Profound Chemopreventative Effects of a Hydrogen Sulfide-Releasing NSAID in the APCMin/+ Mouse Model of Intestinal Tumorigenesis. PLoS ONE. 11(2). e0147289–e0147289. 18 indexed citations
12.
Flannigan, Kyle L., Vu L. Ngo, Duke Geem, et al.. (2016). IL-17A-mediated neutrophil recruitment limits expansion of segmented filamentous bacteria. Mucosal Immunology. 10(3). 673–684. 102 indexed citations
13.
Medina‐Contreras, Óscar, Akihito Harusato, Hikaru Nishio, et al.. (2015). Cutting Edge: IL-36 Receptor Promotes Resolution of Intestinal Damage. The Journal of Immunology. 196(1). 34–38. 105 indexed citations
14.
Blackler, Rory W., Giada De Palma, Anna Mańko, et al.. (2015). Deciphering the pathogenesis of NSAID enteropathy using proton pump inhibitors and a hydrogen sulfide-releasing NSAID. American Journal of Physiology-Gastrointestinal and Liver Physiology. 308(12). G994–G1003. 45 indexed citations
15.
Motta, Jean‐Paul, Kyle L. Flannigan, Terence A. Agbor, et al.. (2015). Hydrogen Sulfide Protects from Colitis and Restores Intestinal Microbiota Biofilm and Mucus Production. Inflammatory Bowel Diseases. 21(5). 1006–1017. 157 indexed citations
16.
Flannigan, Kyle L., Duke Geem, Akihito Harusato, & Timothy L. Denning. (2015). Intestinal Antigen-Presenting Cells. American Journal Of Pathology. 185(7). 1809–1819. 49 indexed citations
17.
Flannigan, Kyle L., et al.. (2015). Hydrogen Sulfide-Based Anti-Inflammatory and Chemopreventive Therapies: An Experimental Approach. Current Pharmaceutical Design. 21(21). 3012–3022. 16 indexed citations
18.
Wallace, John L., Rory W. Blackler, Melissa V. Chan, et al.. (2014). Anti-Inflammatory and Cytoprotective Actions of Hydrogen Sulfide: Translation to Therapeutics. Antioxidants and Redox Signaling. 22(5). 398–410. 135 indexed citations
19.
20.
Wallace, John L., et al.. (2013). Pro-resolution, protective and anti-nociceptive effects of a cannabis extract in the rat gastrointestinal tract.. PubMed. 64(2). 167–75. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linda Vong Breakdown of academic impact, for papers by David T. Bolick Breakdown of academic impact, for papers by Thad W. Vickery Breakdown of academic impact, for papers by Tobias Polte Breakdown of academic impact, for papers by Neil E. Hubbard Breakdown of academic impact, for papers by Yucun Liu Breakdown of academic impact, for papers by Josette Fauvel Breakdown of academic impact, for papers by Rachel Marion‐Letellier Breakdown of academic impact, for papers by Timothy D. Bigby
Rankless by CCL
2026